Request For Proposals (RFPs)
AFTD-ADDF Drug Discovery Grants
The Association for Frontotemporal Degeneration and the Alzheimer’s Drug Discovery Foundation (ADDF) seek to accelerate and support drug discovery for FTD and related disorders through this RFP. Please note, this funding will not support applications for basic research.
– Development of clinical, biochemical, or neuroimaging biomarkers to accelerate drug development and early diagnosis
– High throughput screening in novel cellular assays relevant to FTD
– Identification and in vitro testing of potentially disease modifying compounds or biologics, including medicinal chemistry refinement, ADME, toxicology, pharmacokinetics, and pharmacodynamics studies
– Testing of lead compounds or biologics in a relevant model for preclinical proof of concept
Deadline for Letters of Intent: August 22, 2014